Nerlynx (chemical name: neratinib) was approved by the U.S. Food and Drug Administration (FDA) on July 17, 2017 to treat early-stage, HER2-positive breast cancer for an extended period of time after surgery (doctors calls this extended adjuvant therapy). You take Nerlynx within 2 years after you’ve had surgery and completed a chemotherapy regimen that included Herceptin (chemical name: trastuzumab). Nerlynx is a pill taken by mouth. The recommended dose of Nerlynx is 240 mg (6 tablets) once per day with food for 1 year.
In this section you can learn more about:
- How Nerlynx Works
- Will Nerlynx Work for You?
- What to Expect When Taking Nerlynx
- Nerlynx Side Effects